IP Verse

Methods And Kits For Diagnosing Covid-19 Disease

Patent No. EP4232828 (titled "Methods And Kits For Diagnosing Covid-19 Disease") was filed by Stellenbosch University on Apr 20, 2022. The application was issued on Oct 9, 2024.

Patent Summary

Post-acute COVID-19 diagnostic test that identifies persistent amyloid clotlets in blood to distinguish long-term symptoms from other conditions. A fluorescent dye binds to these abnormal structures, which are then visualized using microscopy or flow cytometry. The test can optionally treat the sample with fibrinolytic enzymes to confirm that the clotlets resist normal breakdown. This approach detects the specific biomarkers of post-acute syndrome without needing viral RNA or antibody tests.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CLINICUM ST GEORGNov 7, 2024WEICKMANN & WEICKMANN PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4232828

STELLENBOSCH UNIVERSITY
Application Number
EP22725531A
Filing Date
Apr 20, 2022
Status
Granted And Under Opposition
Sep 6, 2024
Publication Date
Oct 9, 2024
External Links
Slate, Register , Google Patents